Glaukos (GKOS) Q3 2025 Earnings Call Transcript

At this time, I would like to welcome you to the Glaukos Corporation's Third Quarter 2025 Financial Results Conference Call. Joining me is Glaukos Corporation's Chairman and CEO, Thomas William Burns, ...
Frontiers

Personalising treatment – a new paradigm in the management of rectal cancer

The management of rectal cancer has undergone significant evolution over the past decade, with an increasing recognition that traditional surgery may not ...

Butterfly Network, Inc. (BFLY) Q3 2025 Earnings Call Transcript

Q3 2025 Earnings Call October 31, 2025 8:00 AM EDTCompany ParticipantsMegan Carlson - Interim CFO, Chief Accounting ...
European Medical Journal

Editor’s Pick: Treatment of Type 2 Diabetes: A Comprehensive Review of Recent Improvements, Therapeutic Strategies, Challenges, and Future Perspectives

Type 2 diabetes (T2D) is a chronic metabolic disorder characterised by insulin resistance and impaired insulin secretion, ...
Frontiers

Next-Generation Minimally Invasive Therapies in BPH: Outcomes, Adoption, and Future Directions

We are conducting a two-part exploration of Benign Prostatic Hyperplasia (BPH), reviewing both the historical and the forward ...